Kashima, Yukie
Togashi, Yosuke
Fukuoka, Shota
Kamada, Takahiro
Irie, Takuma
Suzuki, Ayako
Nakamura, Yoshiaki
Shitara, Kohei
Minamide, Tatsunori
Yoshida, Taku
Taoka, Naofumi
Kawase, Tatsuya
Wada, Teiji
Inaki, Koichiro
Chihara, Masataka
Ebisuno, Yukihiko
Tsukamoto, Sakiyo
Fujii, Ryo
Ohashi, Akihiro
Suzuki, Yutaka
Tsuchihara, Katsuya
Nishikawa, Hiroyoshi
Doi, Toshihiko
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19ak0101058)
Article History
Received: 17 June 2020
Accepted: 7 December 2020
First Online: 11 January 2021
Competing interests
: Y. Togashi has received honoraria from Ono, Bristol-Myers Squibb, Chugai, MSD and AstraZeneca, and research funding from KOTAI Biotechnologies. Y. Nakamura reported the research funding from Taiho Pharmaceutical. K. Shitara reported paid consulting or advisory roles for Astellas, Lilly, Bristol-Myers Squibb, Takeda, Pfizer, Ono and MSD; honoraria from Novartis, AbbVie, and Yakult; and research funding from Astellas, Lilly, Ono, Sumitomo Dainippon, Daiichi Sankyo, Taiho, Chugai, MSD and Medi Science. T. Yoshida, N. Taoka and T. Kawase are employed at Astellas Pharma, Inc. M.Chihara and T.Wada are employed at Daiichi Sankyo Co., Ltd. K.Inaki is employed at Daiichi Sankyo RD Novare Co., Ltd. Y. Ebisuno is employed at Takeda Pharmaceutical Company Ltd. S. Tsukamoto and R.Fujii are employed at Axcelead Drug Discovery Partners Inc. A.Ohashi was an employee of Takeda Pharmaceutical Company Ltd. from 2006 to 2018, and reported paid consulting or advisory roles for Ono Pharmaceutical Company Ltd. out of this study. H. Nishikawa. has received honoraria and research funding from Ono Pharmaceutical, Bristol-Myers Squibb and Chugai Pharmaceutical outside of this work as well as research funding from Taiho Pharmaceutical, Daiichi-Sankyo, Kyowa Kirin, Zenyaku Kogyo, Astellas Pharmaceutical, Sumitomo Dainippon Pharmaceutical, Asahi-Kasei, Sysmex, and BD Japan outside of this study. No potential conflicts of interest were disclosed by the other authors.